The ability of strong albumin solution infused intravenously to allocate fluid from the interstitial fluid space in situations relevant to healthcare.
- Conditions
- Healthy adult volunteers, healthy patients undergoing surgery under general anesthesia, and patients in a state of inflammation after having undergone surgery under general anaesthesia (within 24 hrs after the end of the surgery).Therapeutic area: Body processes [G] - Physiological processes [G07]
- Registration Number
- EUCTR2015-001135-20-SE
- Lead Sponsor
- Södertälje sjukhus AB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Healthy volunteers.
Healthy patients undergoing lengthy surgery with expected small hemorrhage.
Patients scheduled for lengthy surgery who have inflammatory disease with expected small hemorrhage.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 45
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Patients with serious cardiac or pulmonary disease.
Health stats corresponding to American Society of Anesthersiologists (ASA) Group III and IV.
Inability to understand Swedish.
Dementia.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method